From predictions to prescriptions: A data-driven response to COVID-19

  • Dimitris Bertsimas
  • , Leonard Boussioux
  • , Ryan Cory-Wright
  • , Arthur Delarue
  • , Vassilis Digalakis
  • , Alexandre Jacquillat
  • , Driss Lahlou Kitane
  • , Galit Lukin
  • , Michael Li
  • , Luca Mingardi
  • , Omid Nohadani
  • , Agni Orfanoudaki
  • , Theodore Papalexopoulos
  • , Ivan Paskov
  • , Jean Pauphilet
  • , Omar Skali Lami
  • , Bartolomeo Stellato
  • , Hamza Tazi Bouardi
  • , Kimberly Villalobos Carballo
  • , Holly Wiberg
  • Cynthia Zeng

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic’s spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast.

Original languageEnglish (US)
Pages (from-to)253-272
Number of pages20
JournalHealth Care Management Science
Volume24
Issue number2
DOIs
StatePublished - Jun 2021

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • General Health Professions

Keywords

  • COVID-19
  • Epidemiological modeling
  • Machine learning
  • Optimization

Fingerprint

Dive into the research topics of 'From predictions to prescriptions: A data-driven response to COVID-19'. Together they form a unique fingerprint.

Cite this